SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Brown RS. Hepatitis C and liver transplantation. Nature. 2005; 436: 973978.
  • 2
    Berenguer M, Crippin J, Gish R, Bass N, Bostrom A, Netto G, et al. A model to predict severe HCV-related disease following liver transplantation. Hepatology. 2003: 38: 3441.
  • 3
    Feray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, et al. The course of hepatitis C virus infection after liver transplantation. Hepatology. 1994; 29: 11371143.
  • 4
    Sallie R, Cohen AT, Tibbs CJ, Portmann BC, Rayner A, O'Grady JG, et al. Recurrence of hepatitis C following orthotopic liver transplantation: a polymerase chain reaction and histological study. J Hepatol. 1994; 21: 536542.
  • 5
    Aardema KL, Nakhleh RE, Terry LK, Burd EM, Ma CK, Moonka DK, et al. Tissue quantification of hepatitis C virus RNA with morphologic correlation in the diagnosis of recurrent hepatitis C virus in human liver transplants. Mod Pathol. 1999; 12: 10431049.
  • 6
    Park YN, Boros P, Zhang DY, Sheiner P, Kim-Schluger L, Thung SN. Serum hepatitis C virus RNA levels and histologic findings in liver allografts with early recurrent hepatitis C. Arch Pathol Lab Med. 2000; 124: 16231627.
  • 7
    Petrovic LM, Villamil FG, Vierling JM, Makowka L, Gellar SA. Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation. Liver Transpl Surg. 1997; 3: 398406.
    Direct Link:
  • 8
    Sreekumar R, Gonzales-Koch A, Maor-Kendler Y, Batts K, Moreno-Luna L, Poterucha J, et al. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation. Hepatology. 2000; 32: 11251130.
  • 9
    Greenson JK, Svoboda-Newman SM, Merion RM, Frank TS. Histologic progression of recurrent hepatitis C in liver transplant allografts. Am J Surg Pathol. 1996; 20: 731738.
  • 10
    Gane EJ, Naoumov NV, Qian KP, Mondelli M, Maertens G, Portmann BC, et al. A longitudinal analysis of hepatitis C virus replication after liver transplantation. Gastroenterology. 1996; 110: 167177.
  • 11
    Berenguer M, Ferrell L, Watson J, Prieto M, Kim M, Rayon M, et al. HCV-related fibrosis progression following liver transplantation: Increase in recent years. J Hepatol. 2000; 32: 673684.
  • 12
    Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, et al. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol. 1997; 92: 14531457.
  • 13
    Sugo H, Balderson GA, Crawford DH, Fawcett J, Lynch SV, Strong RW, et al. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation. Surg Today. 2003; 33: 421425.
  • 14
    Stravitz RT, Shiffman ML, Sanyal AJ, Luketic VA, Sterling RK, Heuman DM, et al. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation. Liver Transpl. 2004; 10: 850858.
  • 15
    Demetris AJ, Eghtesad B, Marcos A, Ruppert K, Nalesnik MA, Randhawa P, et al. Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis. Am J Surg Pathol. 2004; 28: 658669.
  • 16
    Baiocchi L, Tisone G, Palmieri G, Rapicetta M, Pisani F, Orlando G, et al. Hepatic steatosis: a specific sign of hepatitis C reinfection after liver transplantation. Liver Transpl Surg. 1998; 4: 441447.
  • 17
    Banff schema for grading liver allograft rejection: an international consensus document. Hepatology. 1997; 25: 658663.
  • 18
    Prieto M, Berenguer M, Rayon JM, Cordoba J, Arguello L, Carrasco D, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology. 1999; 29: 250256.
  • 19
    Watt KD, Lyden ER, Gulizia JM, McCashland TM. Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome. Liver Transpl. 2006; 12: 134139.
  • 20
    Taggart RA, Terrault NA, Vardanian AJ, Bostrom A, Feng S. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation. Liver Transpl. 2004; 10: 975985.
  • 21
    Belli LS, Burra P, Poli F, Battista Alberti A, Silini E, Zavaglia C, et al. HLA-DRB1 donor-recipient mismatch affects the outcome of hepatitis C disease recurrence after liver transplantation. Gastroenterology. 2006; 130: 695702.
  • 22
    Guido M, Fagiuoli S, Tessari G, Burra P, Leandro G, Boccagni P, et al. Histology predicts cirrhotic evolution of post-transplant hepatitis C. Gut. 2002; 50: 697700.
  • 23
    Russo MW, Firpi RJ, Nelson DR, Schoonhoven R, Shrestha R, Fried MW. Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C. Liver Transpl. 2005; 11: 12351241.
  • 24
    Shiffman ML, Stravitz RT, Contos MJ, Mills AS, Sterling RK, Luketic VA, et al. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation. Liver Transpl. 2004; 10: 12481255.
  • 25
    Vargas V, Krawcynski K, Castells L, Martinez N, Esteban J, Allende H, et al. Recurrent hepatitis C virus infection after liver transplantation: immunohistochemical assessment of the viral antigens. Liver Transpl Surg. 1998; 4: 320327.
  • 26
    Nuovo GJ, Holly A, Wakely P Jr, Frankel W. Correlation of histology, viral load, and in situ viral detection in hepatic biopsies from patients with liver transplantation secondary to hepatitis C infection. Hum Pathol. 2002; 33: 277284.
  • 27
    Fenwick F, Bassendine MF, Agarwal K, Bevitt D, Pumeechockchai W, Burt AD, et al. Immunohistochemical assessment of hepatitis C virus antigen in cholestatic hepatitis after liver transplantation. J Clin Pathol. 2006; 59: 174178.
  • 28
    Schmeding M, Dankof A, Krenn V, Krukemeyer MG, Koch M, Spinelli A, et al. C4d in acute rejection after liver transplantation—a valuable tool in differential diagnosis to hepatitis C recurrence. Am J Transpl. 2006; 6: 523530.
  • 29
    Kimball P, Stravitz T. DR antigens influence graft outcome and HCV recurrence after liver transplantation. Transpl Proc. 2005; 37: 10991100.
  • 30
    Sreekumar R, Rasmussen DL, Wiesner RH, Charlton MR. Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation. Liver Transpl. 2002; 8: 1421.
  • 31
    Smith MW, Walters KA, Korth MJ, Fitzgibbon M, Proll S, Thompson JC, et al. Gene expression patterns that correlate with hepatitis C and progression to fibrosis in liver transplant recipients. Gastroenterology. 2006; 130: 179181.
  • 32
    Ben-Ari Z, Pappo O, Druzd T, Sulkes J, Klein T, Samra Z, et al. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation. Cytokine. 2004; 27: 714.
  • 33
    Heydemann M, Shields P, McCaughan G, Adams D. Cytokines and chemokines in the immune response to hepatitis C infection. Curr Opin Infect Dis. 2001; 14: 279287.
  • 34
    Charo IF, Ransohoff R. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med. 2006; 354: 610621.
  • 35
    Zeremski M, Petrovic LM, Talal AH. Chemokines as inflammatory mediators in chronic hepatitis C virus infection. Hepatology. In press.
  • 36
    Akashi S, Sho M, Kashizuka H, Hamada K, Ikeda N, Kuzumoto Y, et al. A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection. Transplantation. 2005; 80: 378384.